Description

Swiss Pharmaceut Halotestin

Swiss Pharmaceut Halotestin  is presented as a multi-ingredient prohormone product formulated with three steroid-related compounds. According to the reported composition, the active matrix provides a total of 135 mg per serving.

This product should not be confused with the prescription medicine historically marketed under the Halotestin name. Pharmaceutical Halotestin contains fluoxymesterone, while the formula described on this page is presented as a prohormone blend containing 4-DHEA, epiandrosterone and an additional synthetic steroidal ingredient.

Important: the composition below is provisional and should be confirmed using the original Supplement Facts panel, manufacturer documentation and a valid certificate of analysis.

Reported Active Ingredients

Ingredient Profile

17β-(3-ketoethyl)-androstane-3-one, 17α-ol

This ingredient is described by its chemical name as a synthetic steroidal compound. Its presence should be confirmed carefully because small differences in chemical naming can refer to different structures, isomers or commercial ingredients.

The exact identity, purity and quantity of this compound cannot be established from the product name alone. Reliable identification requires the full label, manufacturer specification and analytical documentation for the relevant production batch.

4-DHEA / 4-Andro

4-Androsten-3β-ol-17-one is commonly referred to as 4-DHEA or 4-Andro. It is a steroid-related compound structurally associated with androgen metabolism.

The reported formula provides 50 mg of 4-DHEA per serving. It should not be described as an ordinary vitamin, mineral or conventional nutritional ingredient. Its classification and permitted use may differ between countries.

Epiandrosterone / Epi-Andro

3β-Hydroxyetioallocholan-17-one is commonly known as epiandrosterone or Epi-Andro. Epiandrosterone is an androgen-related steroid metabolite that may be used in products marketed as prohormone formulations.

According to the reported composition, Epi-Andro is the largest component of the blend, providing 75 mg of the total 135 mg active matrix.

Product Classification

Swiss Pharmaceut Halotestin 135 mg should not automatically be classified as a food supplement simply because it is supplied in capsules or tablets. Products containing synthetic or androgen-related steroid compounds may be classified as medicinal products, unauthorised novel foods, prohibited substances or controlled products, depending on the destination country.

Before offering this product online, the seller should verify its legal classification, ingredient status, labelling requirements, import restrictions and permitted advertising claims in every country where the product may be shipped.

Sports and Anti-Doping Notice

Prohormones, anabolic agents and related steroidal compounds may be prohibited under anti-doping regulations. Competitive athletes should assume that use of this type of product may create a significant risk of an adverse analytical finding.

Athletes should not rely solely on the product name or marketing description. The complete ingredient list and applicable anti-doping rules should be reviewed before use.

Safety and Verification Information

This product is not intended to diagnose, treat, cure or prevent any disease. It should not be used without appropriate medical and regulatory assessment. Individuals with hormonal, cardiovascular, liver, kidney or prostate-related conditions should seek professional medical advice.

Do not use during pregnancy or breastfeeding. Keep out of reach of children. The exact serving size, directions, warnings, other ingredients, allergens and storage conditions must be taken directly from the verified product label.

Composition notice: the ingredient profile shown on this page is based on provisional information. It must not be treated as a confirmed manufacturer specification until verified against the original packaging and batch documentation.